These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30273506)

  • 1. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination.
    Burman C; Serra L; Nuttens C; Presa J; Balmer P; York L
    Hum Vaccin Immunother; 2019; 15(2):459-469. PubMed ID: 30273506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia.
    Marshall HS; Lally N; Flood L; Phillips P
    Med J Aust; 2020 Feb; 212(2):89-93. PubMed ID: 31909501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of invasive meningococcal disease and future immunization strategies.
    Taha MK; Bekkat-Berkani R; Abitbol V
    Hum Vaccin Immunother; 2023 Dec; 19(1):2186111. PubMed ID: 37017273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
    Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G
    Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.
    Begum S; Herrera-Restrepo O; Rolland C; Purushotham S; Andani A; Shah H; Kocaata Z
    Hum Vaccin Immunother; 2024 Dec; 20(1):2406613. PubMed ID: 39373020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review.
    Pardo de Santayana C; Tin Tin Htar M; Findlow J; Balmer P
    Epidemiol Infect; 2023 Mar; 151():e57. PubMed ID: 37052295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.
    Balmer P; Burman C; Serra L; York LJ
    Hum Vaccin Immunother; 2018 May; 14(5):1118-1130. PubMed ID: 29565712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not.
    Alderfer JT; Moran MM; Srivastava A; Isturiz RE
    Postgrad Med; 2019 Nov; 131(8):551-554. PubMed ID: 31575310
    [No Abstract]   [Full Text] [Related]  

  • 12. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.
    Hellenbrand W; Koch J; Harder T; Bogdan C; Heininger U; Tenenbaum T; Terhardt M; Vogel U; Wichmann O; von Kries R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1314-43. PubMed ID: 26487381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines.
    Pelton SI
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S3-S11. PubMed ID: 27449148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal vaccine evolution.
    Bona G; Guidi C
    J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents.
    Serra LC; York LJ; Balmer P; Webber C
    J Adolesc Health; 2018 Sep; 63(3):269-279. PubMed ID: 30236996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
    Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
    Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The important lessons lurking in the history of meningococcal epidemiology.
    Borrow R; Findlow J
    Expert Rev Vaccines; 2024; 23(1):445-462. PubMed ID: 38517733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.
    Vickers DM; Anonychuk AM; De Wals P; Demarteau N; Bauch CT
    Vaccine; 2015 Jan; 33(1):268-75. PubMed ID: 24103896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017.
    Nuttens C; Findlow J; Balmer P; Swerdlow DL; Tin Tin Htar M
    Euro Surveill; 2022 Jan; 27(3):. PubMed ID: 35057902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence.
    Alderfer J; Srivastava A; Isturiz R; Burman C; Absalon J; Beeslaar J; Perez J
    Hum Vaccin Immunother; 2019; 15(9):2205-2216. PubMed ID: 30779683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.